Literature DB >> 25720402

Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.

Per Suppa1,2, Harald Hampel3, Lothar Spies2, Jochen B Fiebach4, Bruno Dubois3, Ralph Buchert.   

Abstract

Hippocampus volumetry based on magnetic resonance imaging (MRI) has not yet been translated into everyday clinical diagnostic patient care, at least in part due to limited availability of appropriate software tools. In the present study, we evaluate a fully-automated and computationally efficient processing pipeline for atlas based hippocampal volumetry using freely available Statistical Parametric Mapping (SPM) software in 198 amnestic mild cognitive impairment (MCI) subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI1). Subjects were grouped into MCI stable and MCI to probable Alzheimer's disease (AD) converters according to follow-up diagnoses at 12, 24, and 36 months. Hippocampal grey matter volume (HGMV) was obtained from baseline T1-weighted MRI and then corrected for total intracranial volume and age. Average processing time per subject was less than 4 minutes on a standard PC. The area under the receiver operator characteristic curve of the corrected HGMV for identification of MCI to probable AD converters within 12, 24, and 36 months was 0.78, 0.72, and 0.71, respectively. Thus, hippocampal volume computed with the fully-automated processing pipeline provides similar power for prediction of MCI to probable AD conversion as computationally more expensive methods. The whole processing pipeline has been made freely available as an SPM8 toolbox. It is easily set up and integrated into everyday clinical patient care.

Entities:  

Keywords:  ADNI; Alzheimer’s disease; atlas-based segmentation; fully automated; hippocampus volumetry; magnetic resonance imaging; mild cognitive impairment; prediction

Mesh:

Year:  2015        PMID: 25720402     DOI: 10.3233/JAD-142280

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

2.  [Not Available].

Authors:  O Bartzsch
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

3.  Changes in Volume of Subregions Within Basal Ganglia in Obsessive-Compulsive Disorder: A Study With Atlas-Based and VBM Methods.

Authors:  Jiaxiang Chen; Chong Tian; Qun Zhang; Hui Xiang; Rongpin Wang; Xiaofei Hu; Xianchun Zeng
Journal:  Front Neurosci       Date:  2022-06-20       Impact factor: 5.152

Review 4.  Translating research findings into clinical practice: a systematic and critical review of neuroimaging-based clinical tools for brain disorders.

Authors:  C Scarpazza; M Ha; L Baecker; R Garcia-Dias; W H L Pinaya; S Vieira; A Mechelli
Journal:  Transl Psychiatry       Date:  2020-04-20       Impact factor: 6.222

5.  Neural correlates of episodic memory in the Memento cohort.

Authors:  Stephane Epelbaum; Vincent Bouteloup; Jean F Mangin; Valentina La Corte; Raffaela Migliaccio; Hugo Bertin; Marie O Habert; Clara Fischer; Chabha Azouani; Ludovic Fillon; Marie Chupin; Bruno Vellas; Florence Pasquier; Jean F Dartigues; Fréderic Blanc; Audrey Gabelle; Mathieu Ceccaldi; Pierre Krolak-Salmon; Jacques Hugon; Olivier Hanon; Olivier Rouaud; Renaud David; Genevieve Chêne; Bruno Dubois; Carole Dufouil
Journal:  Alzheimers Dement (N Y)       Date:  2018-05-22

Review 6.  Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review.

Authors:  Hugh G Pemberton; Lara A M Zaki; Olivia Goodkin; Ravi K Das; Rebecca M E Steketee; Frederik Barkhof; Meike W Vernooij
Journal:  Neuroradiology       Date:  2021-09-03       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.